Verici DX (VRCI) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Verici DX

NOTE: This is based on 13 open tips for Verici DX (VRCI)


Verici DX (VRCI)
Latest Quote Price

0.69p

Verici DX (VRCI)
Price Change (%)

2.56%


Latest Bid : 0.65p Latest Ask : 0.70p
High Today : 0.70p Low Today : 0.65p
This Years High : 3.38p This Years Low : 0.52p
Volume : 1,590,210 MKT Cap : £1.69M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Verici DX (VRCI) Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

Verici DX (VRCI) Latest Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2025-07-21 11:25:00 21/07/2025 -40.00%
Sell Steve Moore Premium Only 2025-06-11 16:25:00 11/06/2025 44.00%
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 53.33%
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 86.00%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 91.76%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Verici DX (VRCI) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 0.65p Latest Ask : 0.70p
High Today : 0.70p Low Today : 0.65p
This Years High : 3.38p This Years Low : 0.52p
Volume : 1,590,210 MKT Cap : £1.69M

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Verici DX Tips

Type Tipster SectorScore Start date Performance
Sell Steve Moore Premium Only 2025-07-21 11:25:00 21/07/2025 -40.00%
Sell Steve Moore Premium Only 2025-06-11 16:25:00 11/06/2025 44.00%
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 53.33%
Avoid Steve Moore Premium Only 2024-10-11 14:50:00 11/10/2024 86.00%
Avoid Steve Moore Premium Only 2024-02-14 16:05:00 14/02/2024 91.76%